166 related articles for article (PubMed ID: 28482415)
41. Decline in hepatitis B and C prevalence among hemodialysis patients in Tocantins, Northern Brazil.
Cordeiro VM; Martins BCT; Teles SA; Martins RMB; Cruvinel KPS; Matos MAD; Luz JA; Barreto RADSS; Teles JA; Santos NC; Caetano KAA; Carneiro MADS
Rev Inst Med Trop Sao Paulo; 2018 Jul; 60():e36. PubMed ID: 30066804
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China.
Su Y; Yan R; Duan Z; Norris JL; Wang L; Jiang Y; Xing W; Chen Y; Xiao Y; Li L; Tao J; Wang N
J Med Virol; 2013 Mar; 85(3):425-32. PubMed ID: 23341370
[TBL] [Abstract][Full Text] [Related]
43. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
[TBL] [Abstract][Full Text] [Related]
45. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
[TBL] [Abstract][Full Text] [Related]
46. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
47. [Prevalence of hepatitis B and C viruses in a chronic hemodialysis center in Dakar].
Diouf ML; Diouf B; Niang A; Ka EH; Pouye A; Seck A; Raphenon G; Moreira-Diop T
Dakar Med; 2000; 45(1):1-4. PubMed ID: 14666779
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients.
Kalantar-Zadeh K; Miller LG; Daar ES
Am J Kidney Dis; 2005 Aug; 46(2):290-300. PubMed ID: 16112048
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit.
Lin HH; Huang CC; Sheen IS; Lin DY; Liaw YF
Am J Nephrol; 1991; 11(3):192-4. PubMed ID: 1660221
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C Virus Infection in Kidney Transplant Patients: Current Treatment Options.
Dzekova-Vidimliski P; Sikole A
Exp Clin Transplant; 2017 Dec; 15(6):587-593. PubMed ID: 29219790
[TBL] [Abstract][Full Text] [Related]
51. HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece.
Rigopoulou EI; Stefanidis I; Liaskos C; Zervou EK; Rizos C; Mina P; Zachou K; Syrganis C; Patsidis E; Kyriakopoulos G; Sdrakas L; Tsianas N; Dalekos GN
J Clin Virol; 2005 Sep; 34(1):81-5. PubMed ID: 16009596
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
53. [Prevalence of hepatitis C virus antibodies in a hemodialysis unit].
Rodríguez MI; Estay R; Soto JR; Wolff C; Plubins L; Child R; Armas R
Rev Med Chil; 1993 Feb; 121(2):152-5. PubMed ID: 7508140
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis C virus infection in children in the era of direct-acting antiviral.
Pawlowska M; Sobolewska-Pilarczyk M; Domagalski K
World J Gastroenterol; 2018 Jun; 24(24):2555-2566. PubMed ID: 29962813
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
Li T; Qu Y; Guo Y; Wang Y; Wang L
Liver Int; 2017 Jul; 37(7):974-981. PubMed ID: 27943605
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
57. New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment.
Sorbera MA; Friedman ML; Cope R
J Pharm Pract; 2017 Jun; 30(3):359-365. PubMed ID: 26902648
[TBL] [Abstract][Full Text] [Related]
58. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan.
Lin CY; Lin JY; Chen WP
Nephron; 1993; 65(4):654. PubMed ID: 7508095
[No Abstract] [Full Text] [Related]
60. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
